Pfizer seeking FDA OK for COVID-19 vaccine booster dose

Please subscribe to IBJ to decode this article.

oho -ce eroOf fldeti v1aVbsonsee kDr .saapiiwaSP tsgo IUroontsCzsi. evocipf .- 9t

n eiseno acyrp isd. hostaohpoaaaemhltapeacatcioe tdec h aWiei rthdDhtt r1nThere sk o.o6e pefaro he tyiitd awa mrt nrscno oettffdgiilivyemipltaasdpa wdi ofewsigAon t ib t c lnkdndo aect vtltrgtnermis iueaou ah ddT ssnredeedlerF yinhd phseso

nl lAos eIMt Dkoaat auiitrs n vil nDe dnahoioc1e sm.Oniameet sve tSrtmtae.oapra fhtTewvpoosuatp i atsmrhaioufr ra spbsoioniivehCTPneht tsusleafiaUnlc xnslh ie h lorrea ncmcnuo9toehie sr.orc ngnh -g eo tn otntsk szrddeorddc td tc ree.c hw ilr sdnVe haimno seotgsp atrregaton eaehfn eie aAryFtit cefrirsiw,aea t e ssehlnoe

mno za u tr nepft ntr idgrvdalotch,a inoWfghrenwss tfpi . tts nost c oomn raetttotiahroieirriitr ctoai os elcahrhanath ehnHssl o heinlseO c T i ucdttiee orginiondaow uetg

epaicsjta ,1eesszeit’ssv1aof petop.ohzr o ewehrfoi1y2odn lBa egdvut atietasgTlndneygcletea sotltorn oeehoG avebveeu,rhn6iheg,s e frsrean lAesh crwetdn coaelhuNPhdt5n ua Igu aklhls,el tiyo apie iceitm driv sa iro aah Fci ’iog c m eehl in erfo rrendDt.wr

thonmi—efbd or .livma i r t.hb n mDhd rhse rnci eu scnsrzr esi aae—ti oeed2vglldt0 dwncd0ehooiirf lteit rtin.soUen eeo nceghnanedeiegh eiMnellm tfweeoi mo nsePiS ad

yhp psUrdtoiraias ;lVsJcitla herbtsnnvcin ynliyhdg aane o-p1noecratego vn loeianeastigosz n ftteedfoetag frtuee eoueerqivh.dv eit oa Casv aseoceaM& enmrs’ ie a rtean,pceit at otlndudaaitrr ieiorpa Jsglvoi etSrzgOdh.n9atnD hnahaBdsih . usn ishmhwhineanh m thr tauessn.rIstosesnPT

ec i f en ho otlnhe sm a c.go shhzsashdieeoc rt Soirc.egdarbot ovUoeeftonrpaeehnn ta l sde PraMo tifrel lr.Tsxe rtfepeatt pno

mujdTl tdn sa i sserirc viorsl gilhh tksa sacatsepna iiftparo bannd lbgesaesl sig ;i eg euweaAtgsnoniJrod uarg vu .-hdstto v -aaJ era&eWt eths, k.peie nadat dmil itbtcnmotoeieesf oeoriswththiiuo pr bnexoloo ya oso op d